Hitachi America, Ltd., Power Systems Division recalls PROBEAT-V, software versions 4.8.1S, and 5.1M Radiation therapy system.
- Recall date
- April 15, 2019
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1892-2019
- FDA classification
- Class II
- Brand / firm
- Hitachi America, Ltd., Power Systems Division
- Sold / distributed
- Distributed to accounts located in AZ, MN, and TN. Foreign distribution to Japan.
Why it was recalled
There is a potential for a discrepant target position when using 3D3D matching mode in PIAS (Positioning Image Analysis System) software installed in the PROBEAT-V, proton therapy systems.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
PROBEAT-V, software versions 4.8.1S, and 5.1M Radiation therapy system.
Get recall alerts
Free email alert whenever Hitachi America, Ltd., Power Systems Division has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Hitachi America, Ltd., Power Systems Division